Home LiteratureArticle Details
PMID: 6827654 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Control of adenovirus gene expression: cellular gene products restrict expression of adenovirus host range mutants in nonpermissive cells.

Journal of virology ·Vol. 46 ·No. 1 ·1983-04-00 ·Pages 50-9

Katze MG, Persson H, Johansson BM, Philipson L

Abstract

Adenovirus type 5 (Ad5) host range mutants dl312 and hr-1, with lesions in region E1A (0 to 4.5 map units) of the viral genome, fail to accumulate virus-specific early RNA during infection in HeLa cells. In a recent report, we showed that the addition of anisomycin, a stringent inhibitor of protein synthesis, at 1 h after infection of HeLa cells with hr-1 virus resulted in the accumulation of properly spliced and translatable mRNA from all early regions (M. G. Katze, H. Persson, and L. Philipson, Mol. Cell. Biol. 1:807-813, 1981). Based on these results we proposed a model in which expression of early mutant RNA was achieved through inactivation of a cellular protein normally causing a reduction in the amount of viral RNA. These studies have been extended in the present report, which shows that early viral proteins can be detected in Ad5 dl312- and Ad5 hr-1-infected HeLa cells which have been treated for several hours with anisomycin either shortly after infection or before infection. A pulse of drug treatment also resulted in expression of substantial amounts of adenovirus structural proteins after infection with both Ad5 hr-1 and Ad5 dl312, whereas in drug-free controls no late proteins were detected. The Ad5 hr-1 virus previously reported to be DNA replication negative in nonpermissive HeLa cells was found to replicate its DNA, albeit at low levels, when anisomycin was present either from 1 to 5 h postinfection or for 5 h before infection. When infectious virus production was examined in mutant-infected cells the titer of Ad5 dl312 virus was found to increase at least 500-fold in anisomycin-treated HeLa cells. Taken together, these and our previous results suggest that the block in gene expression characteristic for complementation group I Ad5 host range mutants in HeLa cells can be overcome by inactivating cellular gene products serving as negative regulators of viral gene expression.

MeSH Terms
Adenoviruses, Human/genetics Anisomycin/pharmacology DNA Replication DNA, Viral/analysis Gene Expression Regulation/drug effects Genes, Viral/drug effects HeLa Cells Humans Mutation RNA, Messenger/analysis RNA, Viral/analysis Viral Proteins/analysis,biosynthesis Virus Replication
Chemicals
DNA, Viral RNA, Messenger RNA, Viral Viral Proteins Anisomycin
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Katze M G
Persson H
Johansson B M
Philipson L
References (30)
30 references, click to expand
  1. A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.
    Eur J Biochem. 1974 Jul 1;46(1):83-8 PMID: 4850204
  2. Detection of specific sequences among DNA fragments separated by gel electrophoresis.
    J Mol Biol. 1975 Nov 5;98(3):503-17 PMID: 1195397
  3. Host-range mutants of adenovirus type 5 defective for growth in HeLa cells.
    Virology. 1977 Mar;77(1):319-29 PMID: 841862
  4. Characteristics of a human cell line transformed by DNA from human adenovirus type 5.
    J Gen Virol. 1977 Jul;36(1):59-74 PMID: 886304
  5. Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.
    J Mol Biol. 1977 Jun 15;113(1):237-51 PMID: 881736
  6. Purification and characterization of the phosphorylated DNA-binding protein from adenovirus-type-2-infected cells.
    Eur J Biochem. 1977 Jun 15;76(2):481-90 PMID: 408135
  7. Effect of protein synthesis inhibitors on viral mRNA's synthesized early in adenovirus type 2 infection.
    J Virol. 1978 Jan;25(1):453-8 PMID: 621786
  8. Synthesis of DNA, late polypeptides, and infectious virus by host-range mutants of adenovirus 5 in nonpermissive cells.
    Virology. 1978 Jun 15;87(2):463-7 PMID: 664263
  9. Structure of the adenovirus 2 early mRNAs.
    Cell. 1978 Jul;14(3):695-711 PMID: 688389
  10. Synthesis of a structural adenovirus polypeptide in the absence of viral DNA replication.
    Virology. 1978 Oct 1;90(1):67-79 PMID: 716228
  11. Mapping temperature-sensitive and host-range mutations of adenovirus type 5 by marker rescue.
    Virology. 1978 Nov;91(1):39-50 PMID: 726266
  12. Purification of specific adenovirus 2 RNAs by preparative hybridization and selective thermal elution.
    Nucleic Acids Res. 1979 Feb;6(2):593-607 PMID: 424306
  13. Purification and characterization of an early glycoprotein from adenovirus type 2-infected cells.
    J Virol. 1979 Mar;29(3):938-48 PMID: 448802
  14. Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells.
    Cell. 1979 Jul;17(3):683-9 PMID: 476833
  15. Pre-early adenovirus 5 gene product regulates synthesis of early viral messenger RNAs.
    Cell. 1979 Aug;17(4):935-44 PMID: 487437
  16. An adenovirus type 5 early gene function regulates expression of other early viral genes.
    Proc Natl Acad Sci U S A. 1979 Aug;76(8):3665-9 PMID: 291030
  17. Synthesis and genomic site for an adenovirus type 2 early glycoprotein.
    J Mol Biol. 1980 Feb 5;136(4):375-94 PMID: 7365790
  18. Physical location of host-range mutations of adenovirus type 5; deletion and marker-rescue mapping.
    Virology. 1980 Jul 30;104(2):510-3 PMID: 6994340
  19. Control of adenovirus early gene expression: a class of immediate early products.
    Cell. 1980 Aug;21(1):303-13 PMID: 7407913
  20. Metabolism of mRNA from the transforming region of adenovirus 2.
    Cold Spring Harb Symp Quant Biol. 1980;44 Pt 1,:447-55 PMID: 6933041
  21. DNA replication and the early to late transition in adenovirus infection.
    Cell. 1980 Nov;22(2 Pt 2):523-33 PMID: 7448872
  22. Proteins and messenger RNAs of the transforming region of wild-type and mutant adenoviruses.
    J Mol Biol. 1980 Sep 25;142(3):399-417 PMID: 7463479
  23. Adenovirus early gene products may control viral mRNA accumulation and translation in vivo.
    Cell. 1981 Feb;23(2):485-96 PMID: 7471209
  24. Expression of early adenovirus genes requires a viral encoded acidic polypeptide.
    Proc Natl Acad Sci U S A. 1981 Oct;78(10):6121-5 PMID: 6947217
  25. Control of adenovirus early gene expression: accumulation of viral mRNA after infection of transformed cells.
    J Virol. 1981 Nov;40(2):358-66 PMID: 7321091
  26. Transformation-defective mutant of adenovirus type 5 containing a single altered E1a mRNA species.
    J Virol. 1981 Dec;40(3):657-64 PMID: 7321099
  27. Resolving the functions of overlapping viral genes by site-specific mutagenesis at a mRNA splice site.
    Nature. 1982 Feb 4;295(5848):380-4 PMID: 7057903
  28. Mechanism of activation of early viral transcription by the adenovirus E1A gene product.
    Cell. 1981 Oct;26(2 Pt 2):213-20 PMID: 7332929
  29. A novel mRNA and a low molecular weight polypeptide encoded in the transforming region of adenovirus DNA.
    EMBO J. 1982;1(7):783-9 PMID: 6985356
  30. Control of adenovirus early gene expression: posttranscriptional control mediated by both viral and cellular gene products.
    Mol Cell Biol. 1981 Sep;1(9):807-13 PMID: 9279393
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1983-04-00
Pages
50-9
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC255092
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com